🇺🇸 FDA
Patent

US 11337968

Phenylquinoline compositions for treatment of ocular disorders and conditions

granted A61KA61K31/47A61K31/4709

Quick answer

US patent 11337968 (Phenylquinoline compositions for treatment of ocular disorders and conditions) held by The Board of Regents of the University of Oklahoma expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/47, A61K31/4709, A61K9/0048, A61P